Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: A real-world chart review study
Số trang: 11
Loại file: pdf
Dung lượng: 1.19 MB
Lượt xem: 13
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Daratumumab, a CD38 monoclonal antibody, has demonstrated efficacy as monotherapy and combination therapy across several indications, both among newly-diagnosed and refractory patients with multiple myeloma (MM).
Nội dung trích xuất từ tài liệu:
Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: A real-world chart review study
Nội dung trích xuất từ tài liệu:
Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: A real-world chart review study
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Multiple myeloma Overall response rate Progression-free survival Time to next treatment Drug therapyGợi ý tài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 166 0 0 -
6 trang 165 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 138 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 107 0 0 -
12 trang 87 0 0
-
19 trang 72 0 0
-
17 trang 60 0 0
-
Ebook Canine and feline dermatology drug handbook: Part 2
225 trang 48 0 0 -
Ebook Canine and feline dermatology drug handbook: Part 1
236 trang 45 0 0 -
9 trang 35 0 0